{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Destruxin A5", "Liver fibrosis", "PDGF-B/PDGFR-\u03b2", "Protein\u2013protein interface", "Selective inhibitor"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27322468", "DateCompleted": {"Year": "2017", "Month": "03", "Day": "06"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "04", "Day": "04"}], "ELocationID": ["10.1016/j.ebiom.2016.03.042", "S2352-3964(16)30131-1"], "Language": ["eng"], "Journal": {"ISSN": "2352-3964", "JournalIssue": {"Volume": "7", "PubDate": {"Year": "2016", "Month": "May"}}, "Title": "EBioMedicine", "ISOAbbreviation": "EBioMedicine"}, "ArticleTitle": "Targeting the PDGF-B/PDGFR-\u03b2 Interface with Destruxin A5 to Selectively Block PDGF-BB/PDGFR-\u03b2\u03b2 Signaling and Attenuate Liver Fibrosis.", "Pagination": {"StartPage": "146", "EndPage": "156", "MedlinePgn": "146-56"}, "Abstract": {"AbstractText": ["PDGF-BB/PDGFR-\u03b2\u03b2 signaling plays very crucial roles in the process of many diseases such as liver fibrosis. However, drug candidates with selective affinities for PDGF-B/PDGFR-\u03b2 remain deficient. Here, we identified a natural cyclopeptide termed destruxin A5 that effectively inhibits PDGF-BB-induced PDGFR-\u03b2 signaling. Interestingly and importantly, the inhibitory mechanism is distinct from the mechanism of tyrosine kinase inhibitors because destruxin A5 does not have the ability to bind to the ATP-binding pocket of PDGFR-\u03b2. Using Biacore T200 technology, thermal shift technology, microscale thermophoresis technology and computational analysis, we confirmed that destruxin A5 selectively targets the PDGF-B/PDGFR-\u03b2 interaction interface to block this signaling. Additionally, the inhibitory effect of destruxin A5 on PDGF-BB/PDGFR-\u03b2\u03b2 signaling was verified using in vitro, ex vivo and in vivo models, in which the extent of liver fibrosis was effectively alleviated by destruxin A5. In summary, destruxin A5 may represent an efficacious and more selective inhibitor of PDGF-BB/PDGFR-\u03b2\u03b2 signaling."], "CopyrightInformation": "Copyright \u00a9 2016 The Authors. Published by Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China; Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, China."}], "LastName": "Wang", "ForeName": "Xingqi", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China."}], "LastName": "Wu", "ForeName": "Xuefeng", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China."}], "LastName": "Zhang", "ForeName": "Aihua", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China."}], "LastName": "Wang", "ForeName": "Shiyu", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China."}], "LastName": "Hu", "ForeName": "Chunhui", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China."}], "LastName": "Chen", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China."}], "LastName": "Shen", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China. Electronic address: rxtan@nju.edu.cn."}], "LastName": "Tan", "ForeName": "Renxiang", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China. Electronic address: yangsun@nju.edu.cn."}], "LastName": "Sun", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China. Electronic address: molpharm@163.com."}], "LastName": "Xu", "ForeName": "Qiang", "Initials": "Q"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "EBioMedicine", "NlmUniqueID": "101647039", "ISSNLinking": "2352-3964"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Peptides, Cyclic"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Proteins c-sis"}, {"RegistryNumber": "0", "NameOfSubstance": "destruxin A5"}, {"RegistryNumber": "1B56C968OA", "NameOfSubstance": "Becaplermin"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Receptor, Platelet-Derived Growth Factor beta"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Becaplermin"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["methods"], "DescriptorName": "Computational Biology"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Liver Cirrhosis"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Targeted Therapy"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Peptides, Cyclic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Protein Binding"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-sis"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptor, Platelet-Derived Growth Factor beta"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Andrae J., Gallini R., Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22:1276\u20131312.", "ArticleIdList": ["PMC2732412", "18483217"]}, {"Citation": "Arora A., Scholar E.M. Role of tyrosine kinase inhibitors in cancer therapy. J. Pharmacol. Exp. Ther. 2005;315:971\u2013979.", "ArticleIdList": ["16002463"]}, {"Citation": "Bai F., Xu Y., Chen J., Liu Q., Gu J., Wang X., Ma J., Li H., Onuchic J.N., Jiang H. Free energy landscape for the binding process of Huperzine A to acetylcholinesterase. Proc. Natl. Acad. Sci. U. S. A. 2013;110:4273\u20134278.", "ArticleIdList": ["PMC3600462", "23440190"]}, {"Citation": "Bansal R., Prakash J., Post E., Beljaars L., Schuppan D., Poelstra K. Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice. Hepatology. 2011;54:586\u2013596.", "ArticleIdList": ["21538439"]}, {"Citation": "Bansal R., Prakash J., De Ruiter M., Poelstra K. Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo. J. Control. Release. 2014;179:18\u201324.", "ArticleIdList": ["24491909"]}, {"Citation": "Bataller R., Brenner D.A. Liver fibrosis. J. Clin. Invest. 2005;115:209\u2013218.", "ArticleIdList": ["PMC546435", "15690074"]}, {"Citation": "Beljaars L., Weert B., Geerts A., Meijer D.K., Poelstra K. The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue. Biochem. Pharmacol. 2003;66:1307\u20131317.", "ArticleIdList": ["14505810"]}, {"Citation": "Bonner J.C. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004;15:255\u2013273.", "ArticleIdList": ["15207816"]}, {"Citation": "Borkham-Kamphorst E., Meurer S.K., Van de Leur E., Haas U., Tihaa L., Weiskirchen R. PDGF-D signaling in portal myofibroblasts and hepatic stellate cells proves identical to PDGF-B via both PDGF receptor type \u03b1 and \u03b2. Cell. Signal. 2015;27:1305\u20131314.", "ArticleIdList": ["25819339"]}, {"Citation": "Brennand D.M., Scully M.F., Kakkar V.V., Patel G. A cyclic peptide analogue of loop III of PDGF-BB causes apoptosis in human fibroblasts. FEBS Lett. 1997;419:166\u2013170.", "ArticleIdList": ["9428627"]}, {"Citation": "Chen S.W., Chen Y.X., Zhang X.R., Qian H., Chen W.Z., Xie W.F. Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats. Gene Ther. 2008;15:1424\u20131435.", "ArticleIdList": ["18509379"]}, {"Citation": "Ehnman M., \u00d6stman A. Therapeutic targeting of platelet-derived growth factor receptors in solid tumors. Expert Opin. Investig. Drugs. 2014;23:211\u2013226.", "ArticleIdList": ["24206431"]}, {"Citation": "Gautier B., Miteva M.A., Goncalves V., Huguenot F., Coric P., Bouaziz S., Seijo B., Gaucher J.F., Broutin I., Garbay C. Targeting the proangiogenic VEGF-VEGFR protein\u2013protein interface with drug-like compounds by in silico and in vitro screening. Chem. Biol. 2011;18:1631\u20131639.", "ArticleIdList": ["22195565"]}, {"Citation": "Grassot J., Gouy M., Perri\u00e8re G., Mouchiroud G. Origin and molecular evolution of receptor tyrosine kinases with immunoglobulin-like domains. Mol. Biol. Evol. 2006;23:1232\u20131241.", "ArticleIdList": ["16551648"]}, {"Citation": "Herrero A., Pinto A., Col\u00f3n-Bolea P., Casar B., Jones M., Agudo-Ib\u00e1\u00f1ez L., Vidal R., Tenbaum S.P., Nuciforo P., Valdiz\u00e1n E.M. Small molecule inhibition of ERK dimerization prevents tumorigenesis by RAS\u2013ERK pathway oncogenes. Cancer Cell. 2015;28:170\u2013182.", "ArticleIdList": ["26267534"]}, {"Citation": "Horbert R., Pinchuk B., Johannes E., Schlosser J., Schmidt D., Cappel D., Totzke F., Sch\u00e4chtele C., Peifer C. Optimization of potent DFG-in inhibitors of platelet derived growth factor receptor\u03b2 (PDGF-R\u03b2) guided by water thermodynamics. J. Med. Chem. 2015;58:170\u2013182.", "ArticleIdList": ["25007344"]}, {"Citation": "Ivanov A.A., Khuri F.R., Fu H. Targeting protein\u2013protein interactions as an anticancer strategy. Trends Pharmacol. Sci. 2013;34:393\u2013400.", "ArticleIdList": ["PMC3773978", "23725674"]}, {"Citation": "Kocabayoglu P., Lade A., Lee Y.A., Dragomir A.C., Sun X., Fiel M.I., Thung S., Aloman C., Soriano P., Hoshida Y. \u03b2-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis. J. Hepatol. 2015;63:141\u2013147.", "ArticleIdList": ["PMC4475471", "25678385"]}, {"Citation": "Kondo R., Yano H., Nakashima O., Tanikawa K., Nomura Y., Kage M. Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C. J. Gastroenterol. 2013;48:526\u2013534.", "ArticleIdList": ["22911171"]}, {"Citation": "Krasnoff S.B., Gibson D.M., Belofsky G.N., Gloer K.B., Gloer J.B. New Destruxins from the Entomopathogenic Fungus Aschersonia sp. J. Nat. Prod. 1996;59:485\u2013489."}, {"Citation": "Li Z.J., Ou-Yang P.H., Han X.P. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells. Cell. Signal. 2014;26:141\u2013148.", "ArticleIdList": ["24100264"]}, {"Citation": "Liu Y., Wang Z., Kwong S.Q., Lui E.L., Friedman S.L., Li F.R., Lam R.W., Zhang G.C., Zhang H., Ye T. Inhibition of PDGF, TGF-\u03b2, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib. J. Hepatol. 2011;55:612\u2013625.", "ArticleIdList": ["21251937"]}, {"Citation": "Majumder S., Piguet A.C., Dufour J.F., Chatterjee S. Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis. Eur. J. Pharmacol. 2013;705:86\u201395.", "ArticleIdList": ["23454556"]}, {"Citation": "Miller M.J., Foy K.C., Kaumaya P.T. Cancer immunotherapy: present status, future perspective, and a new paradigm of peptide immunotherapeutics. Discov. Med. 2013;15:166\u2013176.", "ArticleIdList": ["23545045"]}, {"Citation": "M\u00f3csai A., Kov\u00e1cs L., Gergely P. What is the future of targeted therapy in rheumatology: biologics or small molecules? BMC Med. 2014;12:43.", "ArticleIdList": ["PMC3975154", "24620738"]}, {"Citation": "Papalia G.A., Giannetti A.M., Arora N., Myszka D.G. Thermodynamic characterization of pyrazole and azaindole derivatives binding to p38 mitogen-activated protein kinase using Biacore T100 technology and van't Hoff analysis. Anal. Biochem. 2008;383:255\u2013264.", "ArticleIdList": ["18774767"]}, {"Citation": "Patsenker E., Popov Y., Wiesner M., Goodman S.L., Schuppan D. Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro. J. Hepatol. 2007;46:878\u2013887.", "ArticleIdList": ["17258347"]}, {"Citation": "Prosser C.C., Yen R.D., Wu J. Molecular therapy for hepatic injury and fibrosis: where are we? World J. Gastroenterol. 2006;12:509\u2013515.", "ArticleIdList": ["PMC4066080", "16489661"]}, {"Citation": "Reichenbach V., Fern\u00e1ndez-Varo G., Casals G., Or\u00f3 D., Ros J., Melgar-Lesmes P., Weiskirchen R., Morales-Ruiz M., Jim\u00e9nez W. Adenoviral dominant-negative soluble PDGFR\u03b2 improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats. J. Hepatol. 2012;57:967\u2013973.", "ArticleIdList": ["22820479"]}, {"Citation": "Rodriguez L.G., Wu X., Guan J.L. Wound-healing assay. Methods Mol. Biol. 2005;294:23\u201329.", "ArticleIdList": ["15576902"]}, {"Citation": "Shim A.H., Liu H., Focia P.J., Chen X., Lin P.C., He X. Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex. Proc. Natl. Acad. Sci. U. S. A. 2010;107:11307\u201311312.", "ArticleIdList": ["PMC2895058", "20534510"]}, {"Citation": "Suzuki N., Tsumoto K., Hajicek N., Daigo K., Tokita R., Minami S., Kodama T., Hamakubo T., Kozasa T. Activation of leukemia-associated RhoGEF by Galpha13 with significant conformational rearrangements in the interface. J. Biol. Chem. 2009;284:5000\u20135009.", "ArticleIdList": ["PMC2643521", "19074425"]}, {"Citation": "Wang X., Zhang A., Gao J., Chen W., Wang S., Wu X., Shen Y., Ke Y., Hua Z., Tan R. Trichomide A, a natural cyclodepsipeptide, exerts immunosuppressive activity against activated T lymphocytes by upregulating SHP2 activation to overcome contact dermatitis. J. Investig. Dermatol. 2014;134:2737\u20132746.", "ArticleIdList": ["24933319"]}, {"Citation": "Wang X., Wang S., Hu C., Chen W., Shen Y., Wu X., Sun Y., Xu Q. A new pharmacological effect of levornidazole: inhibition of NLRP3 inflammasome activation. Biochem. Pharmacol. 2015;97:178\u2013188.", "ArticleIdList": ["26212544"]}, {"Citation": "Wang X., Zhou Y., He S., Ouyang Z., Feng L., Shen Y., Wu X., Sun Y., Wu X., Xu Q. Obaculactone exerts a novel ameliorating effect on contact dermatitis through regulating T lymphocyte. Int. Immunopharmacol. 2015;28:1\u20139.", "ArticleIdList": ["26003846"]}, {"Citation": "Wear M.A., Walkinshaw M.D. Thermodynamics of the cyclophilin-A/cyclosporin-A interaction: a direct comparison of parameters determined by surface plasmon resonance using Biacore T100 and isothermal titration calorimetry. Anal. Biochem. 2006;359:285\u2013287.", "ArticleIdList": ["17069746"]}, {"Citation": "Westra I.M., Oosterhuis D., Groothuis G.M., Olinga P. Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs. Toxicol. Appl. Pharmacol. 2014;274:328\u2013338.", "ArticleIdList": ["24321339"]}, {"Citation": "Yoshida S., Ikenaga N., Liu S.B., Peng Z.W., Chung J., Sverdlov D.Y., Miyamoto M., Kim Y.O., Ogawa S., Arch R.H. Extrahepatic platelet-derived growth factor-\u03b2, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. Gastroenterology. 2014;147:1378\u20131392.", "ArticleIdList": ["25173753"]}, {"Citation": "Zhang A.H., Wang X.Q., Han W.B., Sun Y., Guo Y., Wu Q., Ge H.M., Song Y.C., Ng S.W., Xu Q. Discovery of a new class of immunosuppressants from Trichothecium roseum co-inspired by cross-kingdom similarity in innate immunity and pharmacophore motif. Chem. Asian. J. 2013;8:3101\u20133107.", "ArticleIdList": ["24108442"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "11", "Day": "24"}, {"Year": "2016", "Month": "3", "Day": "12"}, {"Year": "2016", "Month": "3", "Day": "29"}, {"Year": "2016", "Month": "6", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "6", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "4"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27322468", "PMC4909612", "10.1016/j.ebiom.2016.03.042", "S2352-3964(16)30131-1"]}}], "PubmedBookArticle": []}